AlbaCore Capital Group

AlbaCore Capital Group, established in 2016, is a London-based investment firm specialising in private debt and opportunistic credit investments across Europe. The company employs a fundamental research and relative value approach to preserve capital and achieve attractive returns.

David Allen

Co-Founder, Chief Investment Officer and Managing Partner

Bill Ammons

Partner and Portfolio Manager

7 past transactions

Babylon

Post in 2023
Babylon Healthcare Services Limited is a digital health service provider that operates a subscription-based mobile application designed to enhance access to healthcare. Founded in 2013 and headquartered in London, the company also has offices in several global locations, including the United States, Canada, and Malaysia. The Babylon platform enables users to book virtual consultations with general practitioners, receive treatment advice, and obtain prescriptions. It combines artificial intelligence with medical expertise to deliver personalized health assessments and 24/7 access to healthcare professionals through phone or video calls. The app also offers features for users to ask medical questions and monitor their health, promoting proactive healthcare management. Babylon aims to make healthcare accessible and affordable for individuals worldwide, catering to health plans, enterprises, and private users through its digital care tools.

Aero

Series B in 2022
Aero Technologies, Inc. is an online reseller of flight tickets, specializing in matching air travelers with premium seats and shared charters. Based in San Francisco, California, the company offers a range of services, including online flight booking and ticketing, as well as information on flight destinations and current offers. Aero aims to provide an intimate travel experience by offering individual seats with personalized service and flexibility in booking, ensuring a seamless luxury travel experience for its customers. Established in 2013, Aero has positioned itself as a key player in the premium air travel market.

Aero

Convertible Note in 2022
Aero Technologies, Inc. is an online reseller of flight tickets, specializing in matching air travelers with premium seats and shared charters. Based in San Francisco, California, the company offers a range of services, including online flight booking and ticketing, as well as information on flight destinations and current offers. Aero aims to provide an intimate travel experience by offering individual seats with personalized service and flexibility in booking, ensuring a seamless luxury travel experience for its customers. Established in 2013, Aero has positioned itself as a key player in the premium air travel market.

MindMaze

Venture Round in 2022
MindMaze is a digital neurotherapeutic company that specializes in developing advanced technologies aimed at accelerating brain recovery, learning, and adaptation. Founded in 2012 and headquartered in Lausanne, Switzerland, with additional offices in Zürich, Ecublens, and San Francisco, MindMaze creates medical-grade virtual reality products designed to stimulate neural recovery. Its flagship offering, MindMotionPRO, delivers engaging virtual reality rehabilitation programs that enable patients to follow personalized exercise regimens prescribed by rehabilitation experts. By combining immersive virtual reality, motion capture, and neurophysiological recording technologies, MindMaze allows clinicians to tailor therapies to individual patient needs and optimize rehabilitation delivery. The company also develops intuitive human-machine interfaces that integrate VR, computer graphics, and brain imaging, facilitating applications in gaming, brain-machine control, and healthcare.

Babylon

Debt Financing in 2021
Babylon Healthcare Services Limited is a digital health service provider that operates a subscription-based mobile application designed to enhance access to healthcare. Founded in 2013 and headquartered in London, the company also has offices in several global locations, including the United States, Canada, and Malaysia. The Babylon platform enables users to book virtual consultations with general practitioners, receive treatment advice, and obtain prescriptions. It combines artificial intelligence with medical expertise to deliver personalized health assessments and 24/7 access to healthcare professionals through phone or video calls. The app also offers features for users to ask medical questions and monitor their health, promoting proactive healthcare management. Babylon aims to make healthcare accessible and affordable for individuals worldwide, catering to health plans, enterprises, and private users through its digital care tools.

MindMaze

Venture Round in 2021
MindMaze is a digital neurotherapeutic company that specializes in developing advanced technologies aimed at accelerating brain recovery, learning, and adaptation. Founded in 2012 and headquartered in Lausanne, Switzerland, with additional offices in Zürich, Ecublens, and San Francisco, MindMaze creates medical-grade virtual reality products designed to stimulate neural recovery. Its flagship offering, MindMotionPRO, delivers engaging virtual reality rehabilitation programs that enable patients to follow personalized exercise regimens prescribed by rehabilitation experts. By combining immersive virtual reality, motion capture, and neurophysiological recording technologies, MindMaze allows clinicians to tailor therapies to individual patient needs and optimize rehabilitation delivery. The company also develops intuitive human-machine interfaces that integrate VR, computer graphics, and brain imaging, facilitating applications in gaming, brain-machine control, and healthcare.

Cardiol Therapeutics

Post in 2020
Cardiol Therapeutics Inc. is a clinical-stage life sciences company based in Oakville, Canada, focused on the development of innovative therapies for heart diseases, including acute myocarditis and heart failure. The company specializes in the production of pharmaceutical cannabidiol (CBD) products, with its lead candidate being CardiolRx, a pharmaceutically manufactured oral CBD formulation. Cardiol Therapeutics is also advancing the use of nanotechnology to deliver CBD and other anti-inflammatory drugs directly to inflamed areas of the heart. This approach aims to address the underlying inflammatory processes associated with various heart conditions. The company has received authorization from the United States Food and Drug Administration to conduct clinical studies evaluating the safety and efficacy of CardiolRx in treating heart diseases, further underscoring its commitment to developing effective treatments in the cardiovascular space.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.